PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32193100-6	2020	Sirt1 activators resveratrol (RSV) and SRT1720 (SRT) ameliorated poly I:C-induced hepatic injury observed via histopathologic analysis and decreased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in the PBC murine model.	Resveratrol	17-28	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	177-180	
32193100-6	2020	Sirt1 activators resveratrol (RSV) and SRT1720 (SRT) ameliorated poly I:C-induced hepatic injury observed via histopathologic analysis and decreased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in the PBC murine model.	Resveratrol	17-28	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	149-175	
30619104-5	2018	Treatment with RES (100 mg/kg body weight) attenuated SEB-induced acute liver injury, as indicated by decreased AST levels and cellular infiltration in the liver.	Resveratrol	15-18	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	112-115	
34180933-11	2021	Biochemical analysis showed that RSV significantly downregulated abnormal increases in serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine (CRE) caused by long-term d-gal treatment, which effectively improved pathological damage, increased superoxide dismutase (SOD) activity and decreased the content of malondialdehyde (MDA) in the liver and kidneys.	Resveratrol	33-36	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	135-161	
34180933-11	2021	Biochemical analysis showed that RSV significantly downregulated abnormal increases in serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine (CRE) caused by long-term d-gal treatment, which effectively improved pathological damage, increased superoxide dismutase (SOD) activity and decreased the content of malondialdehyde (MDA) in the liver and kidneys.	Resveratrol	33-36	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	163-166	
34508115-9	2021	In the group treated with AFB2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB2 treated group.	Resveratrol	42-53	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	60-63	
21086752-5	2010	Both resveratrol (5 mg kg(-1) day(-1)) and vitamin E (80 mg kg(-1) day(-1)) treatment significantly reduced AST, ALT, GST, IL-10, TNF-alpha, IFN-gamma, VEGF-A and TGF-beta1 activities and levels of TBARS and nitrite, and elevated albumin content, GSH level and activities of SOD, CAT, GR and GPx, compared to ethanol-treated group.	Resveratrol	5-16	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	108-111